Completed
Assessment of Safety of Olaparib in Chinese Patients With Ovarian Cancer in the Real-World Setting
NCT06324734
- Conditions
- Using NCID Database to Assess the Safety of Olaparib in Chinese Patients With Ovarian Cancer by Examining the Incidence, Seriousness, and Severity of All AE
- Locations
-
- Chinese Academy of Medical Sciences Cancer Hospital Beijing, Beijing Municipality, China